CN Patent

CN102643266B — 一种雷利度胺b晶型的制备方法

Assigned to Hainan Simcere Pharmaceutical Co ltd · Expires 2015-02-18 · 11y expired

What this patent protects

本发明提供了一种LenalidomideB晶型的制备方法，即将Lenalidomide溶解在甲醇、乙醇与四氢呋喃一种或多种溶剂中，溶清后降温结晶，得到上述LenalidomideB晶型。

USPTO Abstract

本发明提供了一种LenalidomideB晶型的制备方法，即将Lenalidomide溶解在甲醇、乙醇与四氢呋喃一种或多种溶剂中，溶清后降温结晶，得到上述LenalidomideB晶型。

Drugs covered by this patent

Patent Metadata

Patent number
CN102643266B
Jurisdiction
CN
Classification
—
Expires
2015-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Hainan Simcere Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.